Suppr超能文献

1例新型冠状病毒肺炎恢复期患者口服中药汤剂治疗肺纤维化:病例报告

Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report.

作者信息

Zhi Na, Mo Qian, Yang Shuo, Qin Yuan-Xing, Chen Hao, Wu Zeng-Guang, Lan Cai-Hong, Zhang Jun, Li Yin-Long

机构信息

Guizhou University of Traditional Chinese Medicine, Guiyang 550002, Guizhou Province, China.

Guizhou University of Traditional Chinese Medicine, Guiyang 550002, Guizhou Province, China.

出版信息

J Integr Med. 2021 Mar;19(2):185-190. doi: 10.1016/j.joim.2020.11.005. Epub 2020 Dec 5.

Abstract

After one-month of oral treatment with traditional Chinese medicine decoction, without using other drugs, the lung inflammatory exudate, pulmonary fibrosis and quality of life of a 61-year-old female patient with corona virus disease 2019 (COVID-19) were significantly improved. No recurrence or deterioration of the patient's condition was found within seven weeks of treatment and follow-up, and no adverse events occurred, indicating that oral Chinese medicine decoction was able to improve the pulmonary inflammation and fibrosis in a patient recovering from COVID-19, but further research is still needed.

摘要

一名61岁的新型冠状病毒肺炎(COVID-19)女性患者在口服中药汤剂治疗一个月后,未使用其他药物,其肺部炎症渗出、肺纤维化及生活质量均有显著改善。在治疗及随访的七周内未发现患者病情复发或恶化,也未发生不良事件,这表明口服中药汤剂能够改善COVID-19康复期患者的肺部炎症和纤维化,但仍需进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验